Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. Cipla has launched an innovative combination of 3 HIV/AIDS ...

The HIV Drugs Market is expected to grow steadily from 2025 to 2035, driven by advancements in antiretroviral therapy and increasing global awareness initiatives. Rising HIV prevalence, improved ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Truvada was also the overall highest-selling drug on the market for the treatment of HIV in 2006 ... such as Aurobindo and Cipla, have developed and received FDA approval for several other ...

In the following year, Cipla received approval from United States Food and Drug Administration (USFDA) to manufacture medicines in bulk for HIV. In 1994, Cipla introduced Deferiprone which was sta ...

“This includes HIV drugs - a large part of spending for treatment ... Aurobindo Pharma Ltd and Cipla Ltd, also tumbled on Monday. The Nifty Pharma index closed 2.65% lower.

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

Efforts to get Gilead’s experimental COVID-19 drug remdesivir to patients in badly-hit India are building after drug maker Cipla announced it had launched the drug in the country. The ...

Cipla Ltd. has expressed optimism about exceeding ... has instructed organizations in other countries to stop disbursing HIV medications purchased with US aid, even if the drugs have already ...